Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Not Confirmed
Not Confirmed
10-12 December, 2025
Cosmoprof IndiaCosmoprof India
Not Confirmed
Not Confirmed
04-06 December, 2025
Not Confirmed
Not Confirmed
05-09 December, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS




Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
10-12 December, 2025
Cosmoprof IndiaCosmoprof India
Industry Trade Show
Not Confirmed
04-06 December, 2025
Industry Trade Show
Not Confirmed
05-09 December, 2025
Digital content

01 Dec 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/12/01/3196843/0/en/Cullinan-Therapeutics-Receives-FDA-Fast-Track-Designation-for-CLN-049-a-Novel-FLT3xCD3-T-Cell-Engager-in-Relapsed-Refractory-Acute-Myeloid-Leukemia.html

20 Nov 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/taiho-oncology-taiho-pharmaceutical-and-cullinan-therapeutics-initiate-rolling-submission-of-new-drug-application-to-us-food-and-drug-administration-for-zipalertinib-for-treatment-of-locally-advanced-or-metastatic-non-small-cel-302621302.html

10 Nov 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/11/10/3184394/0/en/Cullinan-Therapeutics-to-Participate-in-Upcoming-Investor-Conferences-and-Host-Analyst-and-Investor-Event-at-2025-ASH-Annual-Meeting.html

03 Nov 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/11/03/3179412/0/en/Cullinan-Therapeutics-to-Showcase-New-Data-Demonstrating-Compelling-Clinical-Activity-for-CLN-049-a-Novel-FLT3xCD3-T-Cell-Engager-in-AML-Patients-in-an-Oral-Presentation-at-the-67t.html

25 Oct 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/10/25/3174169/0/en/Cullinan-Therapeutics-Shares-Additional-Preclinical-B-Cell-Depletion-Data-for-CLN-978-Supporting-Clinical-Development-Across-Multiple-Autoimmune-Diseases-at-ACR-Convergence-2025.html

13 Oct 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/taiho-oncology-and-cullinan-therapeutics-present-data-on-zipalertinib-in-patients-with-nsclc-with-egfr-mutations-and-active-brain-metastases-at-the-esmo-congress-2025-302581514.html
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE